US$ 23.92
epithalon dosing subcutaneous oral Injectable TrimRX | Epithalon Dosing Protocol:
Description
Post-Market Surveillance Gap: Because AOD-9604 never received FDA approval for any indication, there is no post-market surveillance system capturing safety signals from widespread clinical use

Purity 99%+ CAS Number Status In Stock Dispatch Same-Day (before 2pm) Select Size 130.00 Research verification required
The following are estimated delivery times once your order has been fulfilled and left our warehouse

The neutral phrasing ensures compatibility with institutional procurement policies for research-only compounds
